LivaNova (LIVN) Change in Receivables (2015 - 2026)
LivaNova (LIVN) reported Change in Receivables of $14.7 million for Q1 2026, up 276.51% on a YoY basis from $3.9 million in Q1 2025, and up 200.9% sequentially from $4.9 million in Q4 2025.
LivaNova (LIVN) Change in Receivables (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Change in Receivables data on file, last reported at $14.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 276.51% year-over-year to $14.7 million; the trailing twelve-month figure through Mar 2026 stood at $21.5 million (up 515.19% YoY), and the FY2025 full-year result was $10.7 million, up 196.79% from the prior year.
- Change in Receivables improved to $14.7 million in Q1 2026, from $4.9 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $20.6 million in Q4 2023 to a low of -$9.0 million in Q3 2024.
- A 5-year average of $2.8 million and a median of $3.1 million in 2022 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 853.42% in 2023, while the deepest fall reached 405.89% in 2023.
- Tracing LIVN's Change in Receivables over 5 years: stood at $3.1 million in 2022, then surged by 555.8% to $20.6 million in 2023, then plunged by 69.14% to $6.4 million in 2024, then retreated by 23.41% to $4.9 million in 2025, then surged by 200.9% to $14.7 million in 2026.
- Business Quant data shows LIVN's Change in Receivables at $14.7 million in Q1 2026, $4.9 million in Q4 2025, and -$7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 14.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.67 Mn |
| Mar 31, 2026 | 14.67 Mn |
| Dec 31, 2025 | 4.88 Mn |
| Dec 31, 2025 | 4.88 Mn |
| Sep 30, 2025 | -7.84 Mn |
| Sep 30, 2025 | -7.84 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Sep 30, 2024 | -9.03 Mn |
| Sep 30, 2024 | -9.03 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Dec 31, 2023 | 20.63 Mn |
| Dec 31, 2023 | 20.63 Mn |